# |
PMID |
Sentence |
1 |
23918304
|
We assessed the expression of SphK2 and proliferating cell nuclear antigen (PCNA) (as a proliferative index) by immunohistochemistry in 180 NSCLC patient's formalin-fixed paraffin-embedded tissue blocks.
|
2 |
23918304
|
Relationship between the expression of SphK2 and PCNA and various clinicopathological features in these patients was evaluated.
|
3 |
23918304
|
Statistical analysis showed that expression of SphK2 in NSCLC tissues was strongly associated with PCNA expression, histology grade, live vaccine strain invasion, lymph node status, clinical stage, tumors size, and histology type.
|
4 |
23918304
|
We assessed the expression of SphK2 and proliferating cell nuclear antigen (PCNA) (as a proliferative index) by immunohistochemistry in 180 NSCLC patient's formalin-fixed paraffin-embedded tissue blocks.
|
5 |
23918304
|
Relationship between the expression of SphK2 and PCNA and various clinicopathological features in these patients was evaluated.
|
6 |
23918304
|
Statistical analysis showed that expression of SphK2 in NSCLC tissues was strongly associated with PCNA expression, histology grade, live vaccine strain invasion, lymph node status, clinical stage, tumors size, and histology type.
|
7 |
23918304
|
We assessed the expression of SphK2 and proliferating cell nuclear antigen (PCNA) (as a proliferative index) by immunohistochemistry in 180 NSCLC patient's formalin-fixed paraffin-embedded tissue blocks.
|
8 |
23918304
|
Relationship between the expression of SphK2 and PCNA and various clinicopathological features in these patients was evaluated.
|
9 |
23918304
|
Statistical analysis showed that expression of SphK2 in NSCLC tissues was strongly associated with PCNA expression, histology grade, live vaccine strain invasion, lymph node status, clinical stage, tumors size, and histology type.
|